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CLINICAL SCIENCE
Meibomian GlandMorphology: The Influence of Structural
Variations on Gland Function and Ocular Surface
Parameters
Clara Llorens-Quintana, PhD,* Laura Rico-del-Viejo, PhD,† Piotr Syga, PhD,‡
David Madrid-Costa, PhD,† and D. Robert Iskander, PhD, DSc*
Purpose: To objectively and quantitatively characterize meibomian
gland morphology and to investigate the influence of morphological
variations on gland function and ocular surface and tear
film parameters.
Methods: One hundred fifty subjects were enrolled. The
examinations included tear osmolarity, tear meniscus height,
bulbar conjunctival hyperemia, noninvasive tear film breakup
time, lid margin thickness, foam secretion, meibomian gland
expressibility, count of functioning glands, corneal and conjunc-
tival staining, fluorescein breakup time, lid wiper epitheliopathy,
and Schirmer test. Patient symptoms were assessed using the
Ocular Surface Disease Index questionnaire. Images from non-
contact meibography were analyzed using an automated method
that objectively estimates dropout area, number of glands, gland
length and width, and gland irregularity.
Results: Gland irregularity highly correlated with dropout area (r =
20.4, P , 0.001) and showed significant partial correlations with
fluorescein breakup time (r = 0.162, P = 0.049) and the Ocular
Surface Disease Index questionnaire (r = 20.250, P = 0.002)
Subjects with dropout area ,32% were divided into 2 groups: high
and low irregularity. Gland expressibility was statistically signifi-
cantly different between the 2 groups (U = 319.5, P = 0.006). In the
high irregularity group, gland irregularity correlated with the
Schirmer test (r = 0.530, P = 0.001) and corneal fluorescein staining
(r = 20.377, P = 0.021).
Conclusions: Automated morphological analysis of meibomian
gland structure provides additional quantitative and objective
information regarding gland morphology. The link between dropout
area and gland function is not clear. Assessment of gland irregularity
might better predict gland function and its effects on ocular surface
and tear film parameters.
Key Words: meibomian glands, meibography, meibomian glands
morphology, objective medical image analysis, morphological image
analysis
(Cornea 2019;00:1–7)
Meibomian glands play an important role in maintainingthe ocular surface equilibrium because they secrete the
lipids that form the main part of the tear film lipid layer. The
importance of the tear film lipid layer and its impact on
tear film homeostasis is well known.1,2 The assessment of
meibomian gland morphology is currently receiving much
attention because of the impact of meibomian gland
dysfunction (MGD) in dry eye disease worldwide.2,3 Since
the introduction of noncontact infrared meibography in the
clinical setting,4 both researchers and eye care practi-
tioners have been able to assess the structure of meibo-
mian glands in an easy and patient-friendly manner,
leading to improvement in the diagnosis of MGD and
dry eye disease. Infrared meibography allows the obser-
vation of meibomian gland structure and abnormalities
such as loss, shortening, dilation, or tortuosity of the
glands.5 Meibomian gland loss or dropout has been
previously studied as an indicator of MGD and correlated
with its severity.6 In addition, although less reported,
meibomian gland length and width have also been
studied.7,8 Earlier studies reported subjective grading of
meibomian gland morphological features. However, in the
past few years, the assessment of meibomian gland
morphology is advancing toward an objective and auto-
mated approach because of its numerous benefits.9–12 It
has been suggested that objective and automatic methods
would provide more consistent and reliable results.5 Also,
in addition to meibomian gland dropout area, automated
methods can provide a more complete morphological
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characterization of the glands (such as gland length, width,
shape, contour or tortuosity), leading to improvement in
the diagnosis of MGD.13–15
Only few automated methods, which objectively ana-
lyze meibomian gland structure, have been proposed. How-
ever, these methods provide limited information regarding the
relationship between objective meibomian gland morpholog-
ical parameters and ocular surface and tear film
parameters.9–12 For this reason, the purpose of this study is
to investigate the relationship between objective meibomian
gland morphological features, obtained using an automated
method, and meibomian gland function, tear film quality, and
ocular surface parameters to ascertain what is the impact of
meibomian gland morphological alterations on clinically
relevant ocular surface parameters.
MATERIALS AND METHODS
Subjects
A total of 150 subjects (80 women and 70 men) were
included in this study. The study protocol was reviewed and
approved by the Ethics Committee of San Carlos University
Hospital (Madrid, Spain) and adhered to the tenets of the
Declaration of Helsinki. Mean age 6 SD of the subjects was
of 42 6 17 years (19–88 yrs). Forty-seven (31%) subjects
were current contact lens wearers, of which 2 were daily soft
contact lens wearers, 44 were either monthly or biweekly soft
contact lens wearers, and 1 was a rigid gas permeable contact
lens wearer. Subjects were recruited for the study from the
general public through advertising. Written informed consent
was obtained from all participants after explaining the
purpose and the possible adverse effects of the study. The
clinical examination was carried out in the Faculty of Optics
and Optometry of the Complutense University of Madrid
between October 1, 2016, and September 30, 2017. Inclusion
criteria included being 18 years old or older, being able to
complete the questionnaires, understanding the procedures,
and obtaining evaluable meibography images of the upper
eyelid. Exclusion criteria included history of any active ocular
disease different from dry eye disease and meibomian gland
dysfunction/disease (MGD) (eg, corneal ulcers, herpes sim-
plex, keratitis), any uncontrolled severe systemic disease that
might have affected the eye (eg, Sjögren syndrome, diabetes
type II, dermatological disease), or any ocular surgery or
trauma that could affect the tear film or produce any eyelid
margin abnormality. No exclusion was made regarding the
state of subjects’ meibomian glands because the aim was to
include subjects with varying levels of meibomian gland
health. Contact lens wearers were accepted, but they were
required not to use their contact lenses within a week before
the clinical examination.
Ocular Surface Evaluation
Both dry eye symptomatology and ocular surface
characteristics were assessed in a single visit for the right
eye of each participant. The clinical examination was
performed in the same room with a mean 6 SD room
temperature of 22°C 6 2°C and a mean 6 SD relative
humidity of 30% 6 5%. All ocular measurements were
accomplished by the same investigator and conducted in
ascending order of invasiveness to minimize the effect of the
previous measurement. Measurements included dry eye
symptomatology, tear film osmolarity, tear meniscus height,
bulbar conjunctival hyperemia, noninvasive tear film breakup
time, slit-lamp examination (ocular surface integrity and
eyelid features), and Schirmer test.
Dry eye subjective symptomatology was assessed with
the Ocular Surface Disease Index (OSDI) questionnaire.16
Tear film osmolarity was assessed using the TearLab
osmometer (TearLab, San Diego, CA) according to the
manufacturer’s instructions. The participant was seated with
the chin tilted upward and eyes directed toward the ceiling.
The device pen was positioned just above the lower eyelid, in
the tear meniscus, avoiding contact with the globe during the
measurement. Afterward, the device was returned to the
electronic base to obtain the osmolarity reading. One
measurement of each eye was performed, but only the
reading of the right eye was used for analysis.
Noninvasive measurements were performed using the
Keratograph 5M (K5M; Oculus Optikgerate, Wetzlar, Ger-
many).17 Three measurements of the tear meniscus height,
bulbar conjunctival hyperemia, the first tear film breakup
time, and the average tear film breakup time incidents were
obtained automatically using the software provided with the
K5M. Tear meniscus height was measured perpendicularly to
the lid margin at the central point relative to the pupil center
using an integrated ruler. Ocular redness was automatically
evaluated with K5M software by scanning the image of the
exposed bulbar conjunctiva. The software generates a score
based on the ratio between blood vessels area and total bulbar
conjunctiva area.
Slit-lamp examination of the ocular surface was
performed under diffuse illumination using ·10 to ·16
(Topcon SL-D4, Tokyo, Japan). Corneal staining was
assessed by instilling fluorescein using a fluorescein strip
(Tiedra Laboratories, Madrid, Spain) that was previously
wetted with 1 drop of saline solution (Saline solution;
Avizor, Madrid, Spain) and applied to the eye. Then, the
staining was graded using the Oxford scoring scheme.18
Fluorescein breakup time was measured 3 times with
a stopwatch and was averaged for the subsequent analysis.
In addition, conjunctival staining was assessed using a liss-
amine green strip (Tiedra Laboratories) previously wetted
with 1 drop of saline solution and graded using the Oxford
scoring scheme.
Eyelid features such as lid margin thickness, expressi-
bility, foam secretion, number of functional meibomian
glands, and lid wiper epitheliopathy were evaluated with the
slit lamp. Eyelid margin thickness was assessed on a scale
from 1 to 5, where 1 to 2 = thin; 3 = normal; and 4 to 5 =
thick. Foam secretion was categorized as 0 (absent) or 1
(present). Expressibility from the 8 central meibomian glands
was assessed on a scale from 0 to 3, where 0 = clear meibum
readily expressed; 1 = cloudy meibum expressed with mild
pressure; 2 = cloudy meibum expressed with more than
moderate pressure; and 3 = meibum could not be expressed
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even with strong pressure. The number of functional meibo-
mian glands was assessed on a scale from 0 to 3, where 0 =
more than 5 glands expressible; 1= 3 to 4 glands expressible;
2 = 1 to 2 glands expressible; and 3 = no glands expressible.
Lid wiper epitheliopathy was assessed using a combination of
fluorescein and lissamine green (Korb Protocol B), where the
higher of the final fluorescein or lissamine green staining
score is used as the lid wiper epitheliopathy severity grade (0
= absent, 1 = mild, 2 = moderate, and 3 = severe).19
The modified Schirmer I test was performed with
topical anesthesia (Colirio Anestésico Doble, Spain) and read
at 5 minutes with a cutoff point of 10 mm.20 The Schirmer
strip was placed in the lower conjunctival sac at the junction
of the lateral and middle thirds, and after 5 minutes, the length
of wetting was recorded. Participants were seated, and they
were asked to close the eyes during the test.
Infrared Meibography and Data Analysis
Infrared meibography images of the everted upper
eyelid were acquired with the K5M infrared camera (before
the Schirmer test was performed). Bit map images were
exported and analyzed offline using a recently proposed
automated algorithm that provides a morphometric charac-
terization of the meibomian gland structure. A brief descrip-
tion of the main steps of the method is provided below. For
more technical details, please refer to Llorens-Quintana
et al.21
The algorithm used is based on different image
processing techniques, and it is divided into 3 main
consecutive and automated steps: 1) selection of the area of
analysis which is the tarsal conjunctiva, 2) isolation of the
individual meibomian glands, and 3) extraction of meibomian
gland morphological features (ie, dropout area, gland length,
gland width, number of glands, and gland irregularity). These
morphological features allow an objective and quantitative
description of the general condition of meibomian glands and
a more specific characterization of the gland structure.
The dropout area is calculated as the percentage of the
total analyzed area (ie, the exposed tarsal conjunctiva) that
has gland dropout.
To estimate the length and width of the glands, each
gland is fitted with an ellipse having the same normalized
central moment of the gland. Then, the length and width of
the gland are approximated to the length of the major
and minor axis of the fitted ellipse, respectively. Finally, the
mean length and width of all the exposed glands of the tarsal
conjunctiva is computed and reported.
The number of glands corresponds to the number of
detected and analyzed glands per eyelid.
Gland irregularity is described regarding shape dissim-
ilarity of each gland from a standardized regular gland. To
determine the shape of the standardized gland, the normalized
edge coordinates of 300 regular glands were determined and
averaged, shaping the “standard gland.” Then, the shape of
each detected gland is superposed to the shape of the
“standard gland,” and gland irregularity is defined as their
differential area. To provide a more understandable measure,
this differential area is expressed as a percentage of the total
area of the “regular gland” and it can be understood as the
amount of gland being out of the regular boundaries. Thus,
the higher the extent of the differential area, the greater the
irregularity of the gland. Finally, to provide a global measure
of irregularity per eyelid, the mean irregularity of all the
glands in the exposed tarsal conjunctiva is computed
and reported.
All images were processed in a batch mode with no user
input, and the results were automatically saved. However,
manual selection of the exposed tarsal conjunctiva was allowed
if the algorithm did not properly identify it. This happened in 9
of 150 images, in 6 of which there was an acquisition problem
and in the remaining 3 there was a failure in the preprocessing
steps. In all cases, the following glands isolation and features
extraction steps were performed automatically.
Statistical Analysis
Mean 6 SD (only for continuous measures), median
(IQR), and range of values have been used to describe the
group values for the clinical tests and objective parameters.
Because data were not normally distributed, nonparametric
tests have been used for statistical testing. To assess the
influence of meibomian gland morphology in meibomian
gland function and ocular surface, the correlation among the
objective morphological parameters of meibomian glands and
clinical tests were assessed with 2-tailed Spearman r. Differ-
ences among groups with different irregularity levels have
been assessed with a Mann–Whitney U test for independent
samples. For all statistical tests, a significance level of P ,
0.05 was set.
RESULTS
Raw infrared images of meibomian glands from the
upper eyelid were analyzed in an automated fashion to extract
the objective morphological features. Descriptive values of
the objective features and clinical signs and symptoms for all
participants are shown in Table 1.
Spearman correlations between objective features and
clinical signs and symptoms were assessed to study the
possible effects of meibomian gland morphology on meibo-
mian gland function and ocular surface health.
Table 2 shows those correlations that were statistically
significant. They will be discussed later.
As can be seen, gland irregularity has the opposite trend
to what could be expected, meaning that more irregularity
would entail better ocular surface conditions. However, this
should not be misinterpreted. Gland irregularity is inversely
correlated with the dropout area (Spearman r = 20.4, P ,
0.001). In general, it is more likely that longer glands, which
usually entail less dropout area, could have more irregularity
compared with short glands. Figure 1 shows 3 meibography
images with different dropout areas (ie 5%, 20%, and 61% for
Figures 1A, 1B, and 1C, respectively) and different irregu-
larity levels. It can be noticed that in Figure 1A, where the
glands are long, they are more irregular than those shown in
Figure 1C, where the short glands have less irregularity. In
general, the longer the glands are the more likely they are
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irregular. This can be noted in Figure 1B where the arrow
points to a long and irregular gland and the asterisk
demarcates a group of short glands in which it is more
difficult to find high levels of irregularity.
Accordingly, to avoid the potentially misleading results
of the Spearman correlation, partial correlations between
gland irregularity and clinical signs and symptoms were
computed, setting the dropout area as the control variable.
Irregularity showed statistically significant partial correlations
with the fluorescein breakup time (r = 0.162, P = 0.049) and
OSDI (r = 20.250, P = 0.002). However, it seems that
measuring gland irregularity in those subjects who have
a relatively large dropout area does not provide useful
information about the condition of the meibomian glands.
As discussed above, shortened glands are rarely tortuous.
Thus, the study of gland irregularity was narrowed to subjects
with dropout area #32%. This threshold was chosen because
it divides the sample into 2 groups, according to the amount
of dropout area, with minimal intraclass variance using the
Otsu22 method. Accordingly, 110 of 150 subjects had
a dropout area #32%. This group was composed of 59
women and 51 men with an age range from 19 to 80 years and
a mean 6 SD age of 40 6 17 years. Mean 6 SD irregularity
for this group was 21.16% 6 8.34%. Figure 2 shows the
distribution of gland irregularity for the reduced group. The
reduced group was further divided into 2 subgroups: 1)
subjects with low irregularity and 2) subjects with high
irregularity. Data partitioning was performed using the
k-means clustering algorithm (with k = 2), an iterative
algorithm which assigns each observation to one of the 2
groups so the squared Euclidean distance of each point to
each group centroid is minimal. Accordingly, 72 subjects
formed the group of low irregularity and 38 subjects were
included in the high irregularity group. Mean 6 SD gland
irregularity was 16.35% 6 4.62% and 30.26% 6 5.82% for
the low and high irregularity groups, respectively. The
threshold for this division was an irregularity of 23.2%.
Table 3 shows the values of the clinical parameters for
the high and low irregularity groups. The Mann–Whitney U
test revealed statistically significant differences in gland ex-
pressibility among both groups (U = 319.5, P = 0.006). In the
high irregularity group, Schirmer test results correlated with
irregularity (r = 0.530, P = 0.001), and there was inverse
correlation between corneal staining and irregularity (r =
20.377, P = 0.021) after controlling for the dropout area
variable. In that group, gland expressibility did not correlate
with gland irregularity (r = 20.149, P = 0.380). In addition,
gland irregularity showed no statistically significant correla-
tion with any of the other clinical measures.
DISCUSSION
In this study, the relationship between different meibo-
mian gland morphology descriptors and clinical parameters of
gland function, tear film quality, and ocular surface integrity
has been evaluated using a fully automated analysis.21
Several studies have subjectively evaluated the relation-
ship between meibomian gland dropout and meibomian gland
TABLE 1. Descriptive Statistics for the Extracted Objective
Features, Clinical Tests, and Subjective Questionnaires
Mean 6 SD Median (IQR) Range
Objective features
DOA (%) 21.6 6 15.3 19.5 (23) 0–75
Mean gland
length (mm)
3.3 6 0.6 3.3 (0.9) 1.82–4.59
Mean gland
width (mm)
0.5 6 0.1 0.5 (0.1) 0.3–0.7
Number of glands 17 6 6 18 (7) 3–35
Irregularity (%) 21.6 6 9.4 19.8 (12.5) 0–54.8
Clinical tests
Osmolarity (mOsm/L) 310 6 18 306 (20) 283–385
TMH (mm) 0.26 6 0.08 0.25 (0.09) 0.13–0.53
Bulbar redness 1.11 6 0.50 1.03 (0.70) 0.0–3.33
NIKBUT-fr (s) 8.9 6 5.3 7.0 (6.8) 1.9–23.1
NIKBUT-avg (s) 12.0 6 5.2 11.5 (8.0) 2.1–25
Lid margin thickness
(5-grade scale)
— 4 (1) 2–5
Foam secretion
(2-grade scale)
— 0 (1) 0–1
Expressibility
(4-grade scale)
— 1 (1) 0–3
Number of gland
functioning
(4-grade scale)
— 0 (1) 0–2
Corneal staining
(5-grade scale)
— 1 (1) 0–4
FBUT (s) 4.4 6 2.1 3.7 (2.0) 1.0–16.7
Conjunctival staining
(5-grade scale)
— 1 (1) 0–4
LWE (4-grade scale) — 1 (0) 0–3
Schirmer (mm) 12.0 6 7.2 11.0 (7.0) 0–35.0
Subjective questionnaire
OSDI 16.7 6 15.0 13.1 (17.1) 2.1–75
DOA, dropout area; FBUT, fluorescein breakup time; LWE, lid wiper epitheliop-
athy; NIKBUT-avg, average noninvasive tear film breakup time; NIKBUT-fr, first
noninvasive tear film breakup time; TMH, tear meniscus height.
TABLE 2. Statistically Significant Correlations Between
Objective MG Morphology Features and Clinical Tests
Spearman Correlation P
DOA-TMH 0.247 0.002
DOA-bulbar redness 0.188 0.022
DOA-conjunctival staining 0.193 0.018
Mean gland length-Lid margin thickness 0̶.163 0.046
Mean gland length-FBUT 0.175 0.032
Mean gland width-Lid margin thickness 0̶.162 0.048
Mean gland width-Foam secretion 0̶.177 0.031
Mean gland width-FBUT 0.176 0.031
Mean gland width-Conjunctival staining 0̶.179 0.029
Irregularity-FBUT 0.254 0.013
Irregularity-conjunctival staining 0̶.227 0.027
Irregularity-OSDI 0̶.264 0.010
DOA, dropout are; FBUT, fluorescein breakup time; TMH, tear meniscus height.
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function, ocular surface health, and/or tear film quality. Arita
et al23 scored the area of meibomian gland dropout using
a subjective 4-grade scale (meiboscore) and found that, for
subjects with obstructive MGD, the dropout area significantly
correlated with ocular symptoms, lid abnormalities, fluores-
cein breakup time, and gland expressibility. Using the same
criterion, Finis et al24 found lower but still significant
correlations between the dropout area and the number of
functioning glands in a mixed group of subjects. However,
they concluded that the assessment of the dropout area, as
a single criterion, is not enough to detect impaired meibomian
glands, but it should be interpreted in the context of additional
tests. An interesting fact of the work of Finis et al is that
33.3% of the subjects with no gland loss showed less than 4
functioning glands, suggesting that gland dysfunction also
occurs without gland loss. Rico-del-Viejo et al25 found that
the dropout area correlated with ocular signs only in subjects
with an advanced level of gland loss and reported increased
levels of tear osmolarity and ocular surface staining when the
dropout area was higher than the 50%.
Some authors have used semiautomated methods, such
as ImageJ software, to analyze the dropout area. This
semiautomated method still has some interobserver variability
because the examiner has to manually define the area of
glands. Using such software, Pult and Ride-Pult14 found that,
for a group of 17 subjects, the area of meibomian gland
dropout significantly correlated with the noninvasive breakup
time (r = 20.46, P = 0.032) and OSDI (r = 0.89, P = 0.001).
Similarly, a recent study26 found a slight but still statistically
significant correlation among subjects with MGD between
dropout area and OSDI (r = 0.187, P , 0.05). On the other
hand, Eom et al27 did not find any correlation with fluorescein
breakup time or the Schirmer test, neither in healthy subjects
nor in subjects with MGD. In this study, positive significant
correlations were found between dropout area and bulbar
conjunctival hyperemia and conjunctival staining, which are
indicators of ocular surface irritation and damage that have
been associated with abnormal meibum quality28 and
MGD.29 In agreement with previous findings, where an
increase in tear volume has been found in patients with
MGD,30 we have found a positive and significant correlation
of gland dropout area with tear meniscus height. This is
thought to be the reaction of a compensatory reflex in tearing
due to increased tear evaporation caused by weakened quality
of the tear film lipid layer.31
Discrepancies among cited studies may have different
causes. First of all, the assessment of the dropout area in
previous studies depends on subjective judgments of meibog-
raphy images, whereas in this study, the assessment is
completely objective with no user input. In addition, having
a mixed group of healthy and MGD subjects can be
a drawback when correlating the dropout area with clinical
signs and symptoms because this correlation is expected to be
higher in subjects with MGD with associated
clinical symptomatology.
Other morphological characteristics of meibomian
glands, such as length, width, or shape irregularity, have
been suggested to be valuable when assessing MGD.7,8,32
However, studies investigating the influence of meibomian
gland morphology on meibomian gland function, tear film
characteristics, and ocular surface health are scarce. Ban
et al33 evaluated the length of the 5 central meibomian glands
in a group of healthy subjects using ImageJ. They reported
a mean 6 SD gland length of 5.53 mm 6 1.27 mm, which is
higher compared with what is reported in the present study. In
the work of Ban et al, gland length statistically correlated with
gland expressibility (r = 20.345, P , 0.05), but not with
fluorescein breakup time, contrary to what has been found in
this study. Differences in mean length between both studies
are understandable because Ban et al measured the 5 glands
located at the center of the eyelid (generally the largest
imaged section), whereas we measured the mean length of all
the exposed glands.
FIGURE 1. Example of 3 infrared
meibography images with a dropout
area of 5% (A), 20% (B), and 61%
(C). It can be seen that shortened
glands have low irregularity,
whereas higher levels of irregularity
might be found in longer glands. In
(B), the arrow points a long and
irregular gland and the asterisk de-
marcates a group of glands that are
short and more regular.
FIGURE 2. Histogram of the distribution of gland irregularity
in the group of 110 subjects with dropout area ,32%.
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Meibomian gland width was assessed by Pult et al8 in
a group of 20 random subjects using ImageJ software. The
width of the “worst case gland” was considered to be
representative for the overall eyelid condition. A significant
correlation between worst case gland width and NIBUT (r =
20.761, P , 0.001) and OSDI (r = 0.469, P = 0.033) was
found. Although in some cases the assessment of the worst
gland may be of interest, in general, this is inconclusive
because an eyelid with a single impaired meibomian gland is
equated with an eyelid that has many impaired glands to the
same degree. Finally, they conclude that although gland width
adds some value when evaluating meibomian gland condi-
tion, the most important factor is the area of gland dropout. In
our case, we have found that the mean width of all the glands
is weakly but statistically significantly correlated with lid
margin thickness, foam secretion, fluorescein breakup time,
and conjunctival staining.
Although gland irregularity has been suggested to be
a parameter potentially related to meibomian gland function
and integrity,7,23,27,34 to the best of our knowledge, only 1
study has attempted to assess gland irregularity or tortuos-
ity.15 However, in that study, irregularity was subjectively
assessed as “present” or “absent,” and the analysis of how this
finding may influence meibomian gland function and the
ocular surface condition is lacking. In this study, a quantitative
measure of gland irregularity is reported for the first time.
Nonetheless, it has been seen that the assessment of gland
irregularity only makes sense when glands have a certain mi-
nimum length. Therefore, gland irregularity should be
a measure subjugated to the percentage of dropout area.
When irregularity was assessed in subjects with dropout area
,32%, only gland expressibility showed statistically signif-
icant differences between groups of high and low irregularity.
Although this difference may seem small (1 grading point in
a 4-grade scale), it is considered relevant because it was found
in a group of patients with good gland condition. In addition,
in the high irregularity group, irregularity positively corre-
lated with the Schirmer test, agreeing with the assumption
that compromised gland secretion triggers a compensatory
tearing reflex. Hence, it is suggested that gland irregularity
could be related to the quality and quantity of the expressed
meibum. The lack of other findings related to gland
irregularity supports the theory that gland irregularity is not
a decisive factor when assessing meibomian glands. We
postulate that as long as the gland is not atrophied, it will be
functioning although some changes in lipid secretions and
composition may occur, leading to an alteration of the tear
film properties. Previous studies have demonstrated that
changes in the composition of expressed meibum contribute
to the development of MGD.35–37
One limitation of this study is that only 1 measurement
of tear film osmolarity was performed. When using the
TearLab Osmolarity System, a minimum of 3 measurements
is required to obtain reliable results.38 However, because of
a logistic reason, this was not possible, entailing a lack
of reliability.
The percentage of contact lens wearers in this study is
higher than that reported for developed countries.39 It is not
clear what is the impact of contact lens wear on meibomian
gland morphology.40 In this study, the objective parameters
between contact lens and noncontact lens wearers were not
statistically significantly different (for all parameters, Mann–-
Whitney U test, P . 0.05). In addition, when contact lens
wearers were removed from the analysis, the significance of
TABLE 3. Clinical Parameters Values for Subjects With DOA , 32% Divided Into Low and High Irregularity Groups
Low Irregularity (n = 72) High Irregularity (n = 38)
PMean 6 SD Median (IQR) Range Mean 6 SD Median (IQR) Range
Osmolarity (mOsm/L) 311 6 18 307 (17) 289–385 308 6 17 306 (25.5) 283–344 0.699
TMH (mm) 0.25 6 0.08 0.24 (0.07) 0.13–0.53 0.26 6 0.07 0.25 (0.09) 0.15–0.45 0.801
Bulbar redness 1.07 6 0.48 0.99 (0.77) 0.33–2.80 1.05 6 0.42 0.99 (0.49) 0–2.20 0.897
NIKBUT-fr (s) 8.6 6 4.9 6.7 (5.7) 2.9–24 9.2 6 5.7 7.7 (7.7) 2.0–24 0.159
NIKBUT-avg (s) 11.7 6 4.9 11.0 (7.1) 4.0–24 11.9 6 5.5 11.2 (8.4) 2.1–24 0.265
Lid margin thickness
(5-grade scale)
— 4 (1) 2–5 — 4 (1) 3–5 0.155
Foam secretion (2-grade scale) — 0 (1) 0–1 — 0 (1) 0–1 0.552
Expressibility (4-grade scale) — 1 (1) 0–3 — 0 (1) 0–3 0.006*
Number of glands functioning
(4-grade scale)
— 0 (1) 0–1 — 0 (0.25) 0–2 0.544
Corneal staining (5-grade scale) — 1 (1) 0–4 — 1 (1) 0–4 0.135
FBUT (s) 4.3 6 1.7 3.8 (1.9) 1–10.8 4.9 6 2.9 4.1 (2) 1–16.7 0.137
Conjunctival staining
(5-grade scale)
— 1 (1) 0–4 — 1 (1) 0–3 0.147
LWE (4-grade scale) — 1 (0.75) 0–3 — 1 (0) 0–3 0.109
Schirmer (mm) 11.8 6 6.7 10.5 (6) 0–35 12.4 6 7.8 11.0 (9) 3–35 0.470
OSDI 17.0 6 14.9 14.1 (16.4) 2.1–68.2 14.6 6 14.7 10.4 (16.7) 2–23 0.238
FBUT, fluorescein breakup time; LWE, lid wiper epitheliopathy; NIKBUT-avg, average noninvasive tear film breakup time; NIKBUT-fr, first noninvasive tear film breakup time;
TMH, tear meniscus height.
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correlations did not change. However, if tear film-related
signs and symptoms are exacerbated because of the use of
contact lenses, that could mask the pure assessment of the
effect of meibomian gland morphology on tear film signs
and symptoms.
In summary, according to what has been found in this
study, isolated morphological characteristics of meibomian
glands could not produce a complete assessment of gland
function. Some authors have already proved that by integrat-
ing different tests, the detection rate of MGD can be
improved.8,26 Nevertheless, further efforts are needed to
ascertain whether a composite score that gathers different
meibomian gland morphological features would better
describe the influence of meibomian gland function on
clinical signs and symptoms, producing a more reliable
MGD diagnosis.
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